Stock ATXS ASTRIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Astria Therapeutics, Inc.

Equities

ATXS

US04635X1028

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-05 EDT 		5-day change 1st Jan Change
9.18 USD +2.74% Intraday chart for Astria Therapeutics, Inc. +2.34% +19.53%
05-21 Oppenheimer Adjusts Astria Therapeutics Price Target to $25 From $29, Maintains Outperform Rating MT
05-09 Astria Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ASTRIA THERAPEUTICS, INC. Stock Astria Therapeutics, Inc.
 491M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.01B -
ARGENX SE Stock argenx SE
 22.59B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. ATXS Stock
  4. Charts Astria Therapeutics, Inc.
  5. Sector Chart